Clinical Classification, Screening and Diagnosis for Thalassemia

Hematol Oncol Clin North Am. 2018 Apr;32(2):193-211. doi: 10.1016/j.hoc.2017.11.006.

Abstract

At present, thalassemia diseases are classified into transfusion-dependent thalassemia and non-transfusion-dependent thalassemia. This classification is based on the clinical severity of patients determining whether they do require regular blood transfusions to survive (transfusion-dependent thalassemia) or not (non-transfusion-dependent thalassemia). In addition to the previous terminology of "thalassemia major" or "thalassemia intermedia," this classification has embraced all other forms of thalassemia syndromes such as α-thalassemia, hemoglobin E/β-thalassemia and combined α- and β-thalassemias. Definitive diagnosis of thalassemia and hemoglobinopathies requires a comprehensive workup from complete blood count, hemoglobin analysis, and molecular studies to identify mutations of globin genes.

Keywords: Diagnosis; Non–transfusion-dependent thalassemia (NTDT); Screening; Transfusion-dependent thalassemia (TDT).

Publication types

  • Review

MeSH terms

  • Blood Transfusion
  • Genetic Association Studies
  • Genetic Testing
  • Hemoglobins / genetics
  • Hemoglobins / metabolism
  • Humans
  • Mass Screening
  • Mutation
  • Phenotype
  • Thalassemia / blood
  • Thalassemia / diagnosis*
  • Thalassemia / genetics
  • Thalassemia / therapy
  • alpha-Thalassemia / blood
  • alpha-Thalassemia / diagnosis
  • alpha-Thalassemia / genetics
  • alpha-Thalassemia / therapy
  • beta-Thalassemia / blood
  • beta-Thalassemia / diagnosis
  • beta-Thalassemia / genetics
  • beta-Thalassemia / therapy

Substances

  • Hemoglobins